Enclomiphene vs TRT: which should I consider first?

Short answer

• If you want to preserve or improve fertility (or you’re younger and want to restart your own testosterone production), start with a gonadotropin-stimulating approach such as enclomiphene/clomiphene first.
• If you have primary testicular failure, don’t care about fertility, or need rapid/sustained symptom relief, testosterone replacement therapy (TRT) is usually the better first choice.

Why they’re different (brief)

• Enclomiphene (a selective estrogen receptor modulator; the trans-isomer of clomiphene) stimulates the hypothalamic–pituitary–gonadal axis to raise LH/FSH and restore the testes’ own testosterone production. That preserves or can improve sperm production. Enclomiphene itself (brand studied as Androxal) is not widely available/approved in every country; most clinicians use clomiphene citrate (Clomid, generic) off-label in men.
• TRT delivers exogenous testosterone (gels, injections, pellets), which typically suppresses LH/FSH and reduces or stops sperm production; it treats symptoms reliably and usually more quickly than an HPT-axis approach.

Which to consider first — practical guidance

1. Clarify your goals
   • Fertility desired now or in the future → prefer enclomiphene/clomiphene first.
   • No fertility desire, older, or need fast symptom control → TRT is reasonable first-line.
2. Determine the type of hypogonadism
   • Secondary (low T with low/normal LH) → more likely to respond to enclomiphene/clomiphene.
   • Primary (low T with high LH) → testes likely cannot respond; TRT is usually required.
3. Check baseline tests before any treatment
   • Morning total testosterone (repeat), free testosterone or calculated free, LH, FSH, prolactin, CBC, PSA (if age-appropriate), SHBG as needed.
4. Practical/availability and cost issues
   • Enclomiphene (Androxal) was researched but is not widely available; clomiphene citrate (Clomid, generic) is commonly used off-label and is inexpensive. Insurance may not cover off‑label use.
   • TRT products (AndroGel, Testim, Axiron, Fortesta, Depo‑Testosterone/cypionate, Aveed/testosterone undecanoate, Testopel pellets) are widely available but coverage varies; some formulations are expensive.
5. Safety and monitoring
   • Both require follow-up labs and clinical monitoring. TRT: monitor hematocrit, PSA, testosterone levels, and symptoms. Enclomiphene/clomiphene: monitor testosterone, LH/FSH, mood/visual side effects, and fertility parameters if indicated.

Recommended places to get evaluated/prescribed

• For telemedicine/men’s-health-focused care: Roman, Hims, Vault Health, Defy Medical — they arrange labs, follow-up, and have specific pathways for TRT vs fertility-preserving options. (Compare fees, lab coordination, and whether they will treat fertility issues.)
• For fertility or complex cases: see a reproductive endocrinologist or urologist who specializes in male fertility (ask local academic centers or urology clinics).

Bottom line (one-line)

• If you want to keep or improve fertility and you have secondary hypogonadism, try enclomiphene/clomiphene first; if you have primary testicular failure, don’t need fertility, or need faster symptom relief, TRT is the usual choice. Start with proper labs and specialist/telehealth evaluation to choose and monitor the right therapy.

If you want, tell me your age, whether fertility matters, any current lab numbers (morning testosterone, LH/FSH), and I’ll make a more personalized recommendation and suggest likely medication/formulation choices.